Drug Trial Radar · NCT02282813
Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002
Last checked: Nov 19, 2026Latest source record: Sep 29, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
298
Actual
Start
Apr 2013
Primary completion
May 2015
Study completion May 2015
Sponsor
- Lead sponsor
- OPKO Health, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 4, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This extension study of subjects previously enrolled in studies CTAP101-CL-3001 or CTAP101-CL-3002 allows long term evaluation of the safety and efficacy of CTAP101 Capsules in reducing elevated intact parathyroid hormone (iPTH) and correcting vitamin D insufficiency in stage 3 or 4 chronic kidney disease patients.
Conditions
- Chronic Kidney Disease
- Hyperparathyroidism, Secondary
- Vitamin D Deficiency
Interventions
CTAP101 CapsulesDrug
At week 12, eligible subjects will continue to take 1-2 capsules (30 mcg each capsule) CTAP101 daily
CalcitriolDrug
At week 12, eligible subjects will be randomized to also take calcitriol 0.25 mcg dose one capsule daily
DoxercalciferolDrug
At week 12, eligible subjects will be randomized to also take doxercalciferol 0.5 mcg one capsule daily
ParicalcitolDrug
At week 12, eligible subjects will be randomized to also take paricalcitol 1 mcg one capsule daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants in the Intent to Treat Population With a Mean Reduction in Plasma Intact Parathyroid Hormone (iPTH) of >/= 30% From Baseline Values at End of Treatment (EOT)Time frame: up to 6 months
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.